Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 18;15(3):165-173.
doi: 10.1007/s12522-016-0234-z. eCollection 2016 Jul.

Management of non-obstructive azoospermia

Koji Chiba  1 , Noritoshi Enatsu  1 , Masato Fujisawa  1
Affiliations
Review

Management of non-obstructive azoospermia

Koji Chiba et al. Reprod Med Biol. .

Abstract

Non-obstructive azoospermia (NOA) is defined as no sperm in the ejaculate due to failure of spermatogenesis and is the most severe form of male infertility. The etiology of NOA is either intrinsic testicular impairment or inadequate gonadotropin production. Chromosomal or genetic abnormalities should be evaluated because there is a relatively high incidence compared with the normal population. Although rare, NOA due to inadequate gonadotropin production is a condition in which fertility can be improved by medical treatment. In contrast, there is no treatment that can restore spermatogenesis in the majority of NOA patients. Consequently, testicular extraction of sperm under an operating microscope (micro-TESE) has been the first-line treatment for these patients. Other treatment options include varicocelectomy for NOA patients with a palpable varicocele and orchidopexy if undescended testes are diagnosed after adulthood, although management of these patients remains controversial. Advances in retrieving spermatozoa more efficiently by micro-TESE have been made during the past decade. In addition, recent advances in biotechnology have raised the possibility of using germ cells produced from stem cells in the future. This review presents current knowledge about the etiology, diagnosis, and treatment of NOA.

Keywords: Male infertility; Management; Non‐obstructive azoospermia; Testicular sperm extraction; Treatment.

PubMed Disclaimer

Conflict of interest statement

Koji Chiba, Noritoshi Enatsu, and Masato Fujisawa declare that they have no conflicts of interest to declare.

References

    1. Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J, Lopes P, Tabaste JM, Spira A. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988–1989). Hum Reprod, 1991, 6 (6) 811–816 - PubMed
    1. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet, 1978, 2 (8085) 366 10.1016/S0140‐6736(78)92957‐4 - DOI - PubMed
    1. Palermo G, Joris H, Devroey P, Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet, 1992, 340 (8810) 17–18 10.1016/0140‐6736(92)92425‐F - DOI - PubMed
    1. Devroey P, Liu J, Nagy Z, Goossens A, Tournaye H, Camus M, Steirteghem A, Silber S. Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non‐obstructive azoospermia. Hum Reprod, 1995, 10 (6) 1457–1460 10.1093/HUMREP/10.6.1457 - DOI - PubMed
    1. Schlegel PN. Causes of azoospermia and their management. Reprod Fertil Dev, 2004, 16 (5) 561–572 10.1071/RD03087 - DOI - PubMed

LinkOut - more resources